(P008) Prospective Assessment of Simulated Prone Whole-Breast Radiation Therapy vs Supine Whole-Breast Radiation Therapy With Respiratory Gating: Significant Lung Dose Reduction With Prone Positioning

Publication
Article
OncologyOncology Vol 30 No 4_Suppl_1
Volume 30
Issue 4_Suppl_1

While respiratory-gated RT can reduce the dosimetric parameters for lungs and heart compared with non-gated ER, the results of this study demonstrated a marked further reduction in pulmonary doses for tangentially treated left-sided breast cancer patients, without compromising target coverage.

Samuel M. Richter, MD, Katrina Stellingwerf, CMD, Dwaine Spence, CMD, Kiernan May, CMD, Alexander Banashkevich, MD, Anna Shapiro, MD; SUNY Upstate Medical University

PURPOSE: To prospectively evaluate which of the two most common radiation therapy (RT) techniques best spares organs at risk (OARs) for left-sided breast cancer patients undergoing adjuvant whole-breast RT (WBRT) as part of their breast-conserving treatment.

METHODS: Twenty-five consecutive, node-negative, Tis–T2N0 left-sided breast cancer patients who were candidates for WBRT following lumpectomy were enrolled in this prospective trial. Each patient underwent CT simulation for planning in the supine position with four-dimensional (4D) CT simulation using the Varian Real-Time Position Management respiratory gating system and in the prone position. Respiratory phases in which the heart was maximally displaced from the chest wall were selected as the optimum supine positioning, and a maximum intensity projection (MIP) file was created for treatment planning. If there was no significant cardiac motion, planning was performed with the all-phase MIP set. For each dataset, OARs were identified. Treatment planning utilizing the two CT studies was performed with conformal tangential fields, utilizing a forward-planning field-in-field technique. Dosimetric analysis of each patient’s best supine plan vs her own prone plan was performed.

RESULTS: Twenty-one patients were eligible for plan analysis. Median age was 59 years (range: 28–75 yr). In all patients, the prone position had resulted in significant reductions in lung V5 (P < .0001), V10 (P < .0001), and V20 (P < .0001) compared with best supine positioning. The lung V20 was reduced by 11.66% in the prone position. Evaluated separately, the seven patients (33.3%) whose best supine position incorporated respiratory gating continued to demonstrate a significant reduction in dose to the lung in the prone position.

CONCLUSION: While respiratory-gated RT can reduce the dosimetric parameters for lungs and heart compared with non-gated ER, the results of this study demonstrated a marked further reduction in pulmonary doses for tangentially treated left-sided breast cancer patients, without compromising target coverage.

Proceedings of the 98th Annual Meeting of the American Radium Society - americanradiumsociety.org

Articles in this issue

(S002) A 15-Year Review of Radiation Therapy for Keloids at Two Institutions
(S003) Single-Fraction Radiation Therapy for the Treatment of Multiple Myeloma Bony Metastases Provides Pain Control and Decreases Time to Chemotherapy
(S001) Prognostic Value of Pretreatment Serum Inflammatory Markers in Patients Receiving Radiation Therapy for Oropharyngeal Cancer
(S004) Trend in Second Malignancy Risk for Head and Neck Cancer With Increased Utilization of IMRT: Analysis of SEER Database
(S005) Comparison of Legal Needs of a Group of Patients With Cancer: Economic and Geographic Factors
(S006) Mission Improvement: Lessons From Initiating a Resident-Led Quality Improvement Project on Smoking Cessation at a County Hospital
(S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
(S008) The Effect of Simulation and Treatment Delays for Patients With Oropharyngeal Cancer Receiving Definitive Radiation Therapy in the Era of Risk Stratification Using Smoking and Human Papilloma Virus Status
(S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity
(S011) Comparative Study Between Ileal Conduit and Indiana Pouch After Cystectomy for Patients With Carcinoma of Urinary Bladder
(S010) Computed Tomography–Assessed Measures of Bone Mineral Density and Muscle Mass as Predictors of Survival in Men With Prostate Cancer
(S012) Quantitative Imaging to Evaluate the Malignant Potential of Pancreatic Cysts
(S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
(S014) The Impact of Radiation Therapy on Survival in Surgically Resected, High-Risk Patients With Ampullary Adenocarcinoma: A Population-Based Analysis
(S016) The Impact of Stereotactic Body Radiation Therapy on Overall Survival in Patients With Locally Advanced Pancreatic Cancer
Related Videos
Tailoring neoadjuvant therapy regimens for patients with mismatch repair deficient gastroesophageal cancer represents a future step in terms of research.
Not much is currently known about the factors that may predict pathologic responses to neoadjuvant immunotherapy in this population, says Adrienne Bruce Shannon, MD.
Data highlight that patients who are in Black and poor majority areas are less likely to receive liver ablation or colorectal liver metastasis in surgical cancer care.
Findings highlight how systemic issues may impact disparities in outcomes following surgery for patients with cancer, according to Muhammad Talha Waheed, MD.
Pegulicianine-guided breast cancer surgery may allow practices to de-escalate subsequent radiotherapy, says Barbara Smith, MD, PhD.
Adrienne Bruce Shannon, MD, discussed ways to improve treatment and surgical outcomes for patients with dMMR gastroesophageal cancer.
Barbara Smith, MD, PhD, spoke about the potential use of pegulicianine-guided breast cancer surgery based on reports from the phase 3 INSITE trial.
Patient-reported symptoms following surgery appear to improve with the use of perioperative telemonitoring, says Kelly M. Mahuron, MD.
Treatment options in the refractory setting must improve for patients with resected colorectal cancer peritoneal metastasis, says Muhammad Talha Waheed, MD.
Although immature, overall survival data from the KEYNOTE-868 trial may support the use of pembrolizumab plus chemotherapy in patients with endometrial cancer.
Related Content